<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

ZenBio Engages Cryoport to Support Distribution of its Human Cell-Based Products

July 14, 2015

Read More


Tags: Global Cold Chain Logistics, Human Platelet Lysate, ZenBio, regenerative therapies

Cryoport Selected for Logistics Support of CaRE Arthritis Personalized Medicine Efforts

June 17, 2015

Read More


Tags: Cold Chain Logistics, Personalized Medicine, CaRE Arthritis

Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider

June 10, 2015

Lake Forest, CA, June 10, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been selected by Lynden International (“Lynden”) as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.

Read More


Tags: Clinical Trials Logistics, cryogenic frozen, Global Cold Chain Logistics, Lynden

Cryoport Supports ArunA Biomedical’s Cryogenic Shipments of Stem Cell Kits

June 3, 2015

Lake Forest, CA, June 3, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is supporting ArunA Biomedical’s (“ArunA”) cryogenic shipments of stem cell kits.

Read More


Tags: Cold Chain Logistics, ArunA, stem cell kits

Cryoport Supports South Mountain Pet Care with Cryogenic Logistics Solutions

May 27, 2015

Lake Forest, CA, May 26, 2015 - Cryoport, Inc. (OTCBB: CYRXD) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is supporting South Mountain Pet Care (“SMPC”) with cryogenic logistics solutions for its canine reproduction business.

Read More


Tags: frozen shipping solution, cryogenic frozen, Animal Husbandry, canine reproduction

Cryoport Reports Record Revenues for Fourth Quarter and Fiscal Year 2015

May 19, 2015

LAKE FOREST, CA – May 19, 2015 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three and twelve-month periods ended March 31, 2015.

Read More


Tags: Revenue, fiscal 2015, Cold Chain Logistics

Cryoport to Present its FY2015 Results and Business Update at the 2015 Marcum Microcap Conference

May 7, 2015

Lake Forest, CA, May 7, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal husbandry and reproductive medicine, announced today that its Chief Executive Officer, Jerrell Shelton, is scheduled to present at the 2015 Marcum MicroCap Conference at the Grand Hyatt in New York City on Thursday, May 28, 2015 at 9:30 a.m. EDT.

Read More


Tags: Frozen Shipping, 24/7 Support, Marcum, Cold Chain Logistics

Cryoport Supports NeoStem’s Intus Study for the Treatment of Metastatic Melanoma

April 29, 2015

Lake Forest, CA, April 29, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is supporting NeoStem, Inc.’s (NASDAQ: NBS) Intus Study to evaluate its lead cancer immunotherapy, NBS20, for the treatment of metastatic melanoma.

Read More


Tags: Frozen Shipping, Biopharmaceutical Cold Chain, NeoStem, Metastatic melanoma, Intus Study

Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms

April 23, 2015

Lake Forest, CA, April 23, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that the Company has further established its cryogenic logistics solutions within the animal husbandry market by signing a new customer agreement with Yancey Farms to support the shipment of equine semen for artificial insemination of top German Sport horse Stallions.

Read More


Tags: Global Cold Chain Logistics, Animal Husbandry, Yancey Farms

Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA

April 21, 2015

Lake Forest, CA, April 21, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that Dr. Mark W. Sawicki, Chief Commercial Officer, will present at the 3rd Annual BioLogistics Summit in San Francisco on Wednesday, July 15th, 2015, at 2:15 p.m. PT. Dr. Sawicki will discuss advanced logistics for both clinical samples and commercial finished goods of emerging cell and gene therapies.

Read More


Tags: frozen shipping solution, Cold Chain Logistics, International Shipping, BioLogistics Summit San Francisco